These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9580203)

  • 21. [Tobacco smoking and biochemical acute phase markers among the patients with chronical periodontal disease].
    Kurhańska-Flisykowska A; Sobieska M
    Przegl Lek; 2008; 65(10):483-5. PubMed ID: 19189528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
    J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
    Straub RH; Vogl D; Gross V; Lang B; Schölmerich J; Andus T
    Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic intestinal inflammation and seronegative spondyloarthropathy in children.
    Conti F; Borrelli O; Anania C; Marocchi E; Romeo EF; Paganelli M; Valesini G; Cucchiara S
    Dig Liver Dis; 2005 Oct; 37(10):761-7. PubMed ID: 16024303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
    Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential role of soluble angiopoietin-2 and Tie-2 in patients with inflammatory bowel disease.
    Koutroubakis IE; Xidakis C; Karmiris K; Sfiridaki A; Kandidaki E; Kouroumalis EA
    Eur J Clin Invest; 2006 Feb; 36(2):127-32. PubMed ID: 16436095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The time is right for acute phase protein assays.
    Eckersall PD
    Vet J; 2004 Jul; 168(1):3-5. PubMed ID: 15158201
    [No Abstract]   [Full Text] [Related]  

  • 29. B2 microglobulin: is it a reliable marker of activity in inflammatory bowel disease?
    Zissis M; Afroudakis A; Galanopoulos G; Palermos L; Boura X; Michopoulos S; Archimandritis A
    Am J Gastroenterol; 2001 Jul; 96(7):2177-83. PubMed ID: 11467650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Helicobacter species in chronic liver disease and chronic inflammatory bowel disease.
    Veijola L; Nilsson I; Halme L; Al-Soud WA; Mäkinen J; Ljungh A; Rautelin H
    Ann Med; 2007; 39(7):554-60. PubMed ID: 17852032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of serological markers in inflammatory bowel disease.
    Mokrowiecka A; Daniel P; Słomka M; Majak P; Malecka-Panas E
    Hepatogastroenterology; 2009; 56(89):162-6. PubMed ID: 19453050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.
    Papadia C; Sherwood RA; Kalantzis C; Wallis K; Volta U; Fiorini E; Forbes A
    Am J Gastroenterol; 2007 Jul; 102(7):1474-82. PubMed ID: 17459021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Redox homeostasis in inflammatory bowel diseases].
    Blázovics A; Szentmihályi K; Prónai L; Hagymási K; Lugasi A; Kovács A; Fehér J
    Orv Hetil; 2004 Jul; 145(28):1459-66. PubMed ID: 15366712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating adiponectin as a marker for glucocorticoid-related side effects in children and adolescents with inflammatory bowel disease.
    Vihinen MK; Kolho KL; Jänne OA; Andersson S; Raivio T
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48(4):504-6. PubMed ID: 19322063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory and long-term risk markers.
    Levinson SS
    Clin Lab Med; 2006 Sep; 26(3):553-70, v. PubMed ID: 16938584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of the acid glycoprotein heterogeneity in patients with arthritis].
    Domysławska I; Lewandowski B; Kita K; Klimiuk PA; Sierakowski S
    Pol Merkur Lekarski; 2004 Oct; 17(100):349-52. PubMed ID: 15690699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated serum PIIINP and laminin in inflammatory bowel disease indicate hepatobiliary and pancreatic dysfunction.
    Heikius B; Niemelä O; Niemelä S; Karttunen TJ; Lehtola J
    Hepatogastroenterology; 2002; 49(44):404-11. PubMed ID: 11995461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise and inflammatory bowel disease: immunological aspects.
    D'Incà R; Varnier M; D'Odorico A; Sturniolo GC
    Exerc Immunol Rev; 2000; 6():43-53. PubMed ID: 10919061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative stress and cardiovascular disease in hemodialysis.
    Boaz M; Green M; Fainauru M; Smetana S
    Clin Nephrol; 2001 Feb; 55(2):93-100. PubMed ID: 11269689
    [No Abstract]   [Full Text] [Related]  

  • 40. [Significance of acute-phase inflammatory reactants as an indicator of prognosis after acute myocardial infarction: which is the most useful predictor?].
    Katayama T; Nakashima H; Yonekura T; Honda Y; Suzuki S; Yano K
    J Cardiol; 2003 Aug; 42(2):49-56. PubMed ID: 12964514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.